Effect of Postmenopausal Estrogen Replacement on Plasma Lp(a) Lipoprotein Concentrations

Archives of Internal Medicine

Volumn 154, Issue 10, 1994, Pages 1106-1110

  Sacks, Frank M ^a,b   Mcpherson, Ruth ^c,d   Walsh, Brian W ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; CONJUGATED ESTROGEN; LIPOPROTEIN A;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; GLYCOPROTEINS; HUMANS; LIPOPROTEIN(A); POSTMENOPAUSE;

EID: 0028282823     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1994.00420100084011     Document Type: Article

References (31)

1. Stampfer MJ, Colditz GA, Willett WC. Menopause and heart disease: a review. Ann N Y Acad Sci. 1989;592:193-203.
2. Henderson BE, Ross RK, Paganini-Hill A, Mack TM. Estrogen use and cardiovascular disease. Am J Obstet Gynecol. 1986;154:1181-1186.
3. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-1109.
4. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses’ Health Study. N Engl J Med. 1991;325:756-762.
5. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991;325:1196-1204.
6. Scanu AM, Fless GM. Lipoprotein (a): heterogeneity and biological relevance. J Clin Invest. 1990;85:1709-1715.
7. Rader DJ, Brewer HB. Lipoprotein(a): clinical approach to a unique atherogenic lipoprotein. JAMA. 1992;267:1109-1112.
8. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 1986;74:758-765.
9. Seed M, Hoppichler F, Reaveley D, et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med. 1990;322:1494-1499.
10. Sandholzer CH, Boerwinkle E, Soha N, Tong MC, Utermann G. Apolipoprotein (a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for a role of the apo (a) gene in coronary heart disease. J Clin Invest. 1992;89:1040-1046.
11. Solymoss BC, Marcil M, Wesolwoska E, Gilfix BM, Lesperance J, Campeau L. Relation of coronary artery disease in women less that 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high density cholesterol ratio. Am J Cardiol. 1993;72:1215-1219.
12. Windier E, Kovanen PT, Chao YS, Brown ML, Havel RJ, Goldstein JL. The estradiol-stimulated lipoprotein receptor of rat liver. J Biol Chem. 1980;255:19464-19471.
13. Mann WA, Kraft HG, Rader DJ, et al. Human in vivo catabolism of lipoprotein (a). Circulation. 1989;890:II-181.
14. Hofmann SL, Eaton DL, Brown MS, McConathy WJ, Goldstein JL, Hammer RE. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest. 1990; 85:1542-1547.
15. Henriksson P, Angelin B, Berglund L. Hormonal regulation of serum Lp(a) levels: opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest. 1992;89:1166-1171.
16. Lipid Metabolism Branch, Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute. The Lipid Research Clinics Population Studies Data Book, Vol 1: The Prevalence Study. Bethesda, Md: National Institutes of Health; 1980. National Institutes of Health publication 80-1527.
17. Albers JJ, Marcovina SM. Apolipoprotein measurements. In: Kornberg RA, Segrest JP, eds. Plasma Lipoproteins and Coronary Heart Disease. Boston, Mass: Blackwell Scientific Publications; 1992:277.
18. Marcel YL, McPherson R, Hogue M, et al. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipidemic subjects. J Clin Invest. 1990;85:10-17.
19. McPherson R, Mann CJ, Tall AR, et al. Plasma cholesteryl ester transfer protein in hyperlipoproteinemia. Arterioscler Thromb. 1991;11:797-804.
20. Rosner B. Multivariate methods for clustered binary data with more than one level of nesting. J Am Stat Assoc. 1989;84:373-380.
21. Heinrich J, Sandkamp M, Kokott R, Schulte H, Assmann G. Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem. 1991;37:1950-1954.
22. Meihahn EN, Kuller LH, Matthews KA, Stein EA. Lp(a) concentrations among pre- and postmenopausal women over time: the Healthy Women Study. Circulation. 1991;84(suppl II):II-2170.
23. Lobo RA, Notelovitz M, Bernstein L, Khan FY, Ross RK, Paul WL. Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen. Am J Obstet Gynecol. 1992;166:1182-1190.
24. Soma MR, Osnago-Gadda I, Paoletti R, et al. The lowering of lipoprotein (a) induced by estrogen plus progestogen replacement therapy in postmenopausal women. Arch Intern Med. 1993;153:1462-1468.
25. Farish E, Rolton HA, Barnes JF, Hart DM. Lipoprotein (a) concentrations in postmenopausal women taking norethisterone. BMJ. 1991;303:694.
26. Rader DJ, Cain W, Zech LA, Kindt M, Usher D, Brewer HB. Lp(a): plasma levels in individuals with the same apo(a) isoprotein are determined by differences in production rates. Circulation. 1992;84:565.
27. Ma PT, Yamamoto T, Goldstein JL, Brown MS. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha ethinyl estradiol. Proc Natl Acad Sci U S A. 1986;83:792-796.
28. Cushing GL, Gaubatz JW, Nava ML, et al. Quantitation and localization of apolipoproteins (a) and B in coronary artery bypass vein grafts resected at reoperation. Arteriosclerosis. 1989;9:593-603.
29. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U. Detection and quantification of lipoprotein (a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis. 1989;9:579-592.
30. Smith EB, Cochran S. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein, II: preferential immobilization of lipoprotein (a). Atherosclerosis. 1990;84:173-181.
31. Bihari-Varga M, Gruber E, Rotherender M, et al. Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis. 1988;8:851-857.